• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Why Denali Therapeutics' Stock Rose 6.6% on Wednesday

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Nov 02, 2022 at 10:52: PM
via
  • Denali Therapeutics specializes in treating neurodegenerative disorders.
  • The company released preliminary phase 1/2 data on an Alzheimer's therapy.
  • Denali isn't profitable, but it does have $1.16 billion in cash.

article source
 




Top Bottom
Back
Quote